COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1386: Articles 13851-13860  | Next

Investigating the conformational dynamics of SARS-CoV-2 NSP6 protein with emphasis on non-transmembrane 91-112 & 231-290 regions
Kumar, A., Kumar, P., Saumya, K. U., Giri, R.
10.1101/2021.07.06.451329 — Posted: 2021-07-07
Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements
Cahyani, I., Putro, E. W., Ridwanuloh, A. M., Wibowo, S., Hariyatun, , Syahputra, G., Akbariani, G., Utomo, A. R., Ilyas, M., Loose, M. W., Kusharyoto, W., Susanti, S.
10.1101/2021.07.06.451270 — Posted: 2021-07-07
Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection
Wang, R., Hume, A., Beermann, M. L., Simone-Roach, C., Lindstrom-Vautrin, J., Le Suer, J., Huang, J., Olejnik, J., Villacorta-Martin, C., Bullitt, E., Hinds, A., Ghaedi, M., Werder, R., Abo, K., Wilson, A., Muhlberger, E., Kotton, D. N., Hawkins, F. J.
10.1101/2021.07.06.451340 — Posted: 2021-07-07
A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters
Sun, W., Liu, Y., Amanat, F., Gonzalez-Dominguez, I., McCroskery, S., Slamanig, S., Coughlan, L., Rosado, V., Lemus, N., Jangra, S., Rathnasinghe, R., Schotsaert, M., Martinez, J., Sano, K., Mena, I., Innis, B. L., Wirachwong, P., Thai, D. H., Oliveira, R. D. N., Scharf, R., Hjorth, R., Raghunandan, R., Krammer, F., Garcia-Sastre, A., Palese, P.
10.1101/2021.07.06.451301 — Posted: 2021-07-07
Nonclinical Safety and Immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs
Madar-Balakirski, N., Rosner, A., Melamed, S., Politi, B., Steiner, M., Tamir, H., Yahalom Ronen, Y., Bar-David, E., Ben-Shmuel, A., Sittner, A., Glinert, I., Weiss, S., Bar-Haim, E., Cohen, H., Elia, U., Achdout, H., Erez, N., Rotem, S., Lazar, S., Nyska, A., Yitzhaki, S., Beth-Din, A., Levy, H., Paran, N., Israely, T., Marcus, H.
10.1101/2021.07.06.451119 — Posted: 2021-07-07
T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
Nersisyan, S., Zhiyanov, A., Shkurnikov, M., Tonevitsky, A.
10.1101/2021.07.06.451227 — Posted: 2021-07-07
SARS-CoV-2 genome sequencing with Oxford Nanopore Technology and Rapid PCR Barcoding in Bolivia
Rollano-Penaloza, O. M., Delgado, C., Vasquez, A.
10.1101/2021.07.06.451357 — Posted: 2021-07-07
Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants
Troitskaya, L., Chan, N. L. S., Frank, B., Capon, D., Zabel, B. A., Ge, X., Luo, D., Martinelli, R., Jin, J., Simmons, G.
10.1101/2021.07.05.451203 — Posted: 2021-07-07
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques
He, W.-t., Yuan, M., Callaghan, S., Musharrafieh, R., Song, G., Silva, M., Beutler, N., Lee, W.-H., Yong, P., Torres, J. L., Melo, M., Zhou, P., Zhao, F., Zhu, X., Peng, L., Huang, D., Anzanello, F., Ricketts, J., Parren, M., Garcia, E., Ferguson, M., Rinaldi, W., Rawlings, S. A., Nemazee, D., Smith, D. M., Briney, B., Safonova, Y., Rogers, T., Crotty, S., Irvine, D. J., Ward, A. B., Wilson, I. A., Burton, D. R., Andrabi, R.
10.1101/2021.07.05.451222 — Posted: 2021-07-06
Application of nasal spray containing dimethyl sulfoxide (DSMO) and ethanol during the COVID-19 pandemic may protect healthcare workers: A randomized controlled trials
Hosseinzadeh, A., Emamian, M. H., Tavakkolian, A., Kia, V., Ebrahimi, H., Sheibani, H., Binesh, E., Jafari, R., Mirrezaie, S. M., Jafarisani, M.
10.1101/2021.07.06.21259749 — Posted: 2021-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).